Minas Tanes

Chairman of the Board

Born in Athens, he studied in the Economic University. He holds a master in Management Science and Operational Research and a diploma for the Program of Executive Development from IMEDE in Switzerland. He started his career in 1966 at the British Iron and Steel Research Association. From 1970 to 1973 he worked in Esso Pappas as an executive member in Program and Research Financing. He joined Athenian Brewery (Amstel, Heineken) as a Finance Director in 1973 and from 1976 to 2005  he held the position of CEO. In 2008 he stepped away as Chairman, with a legacy of the longest and most successful CEO. For his accomplishment to keep the company among the biggest and growing companies of the Greek market, he was awarded by various institutions, including EEDE. He has served as member of the General Council of SEV and as President of IOVE. He has sat at board of many companies and organisations, such as Global Finance and Alpha Bank. At Lavipharm, he was nominated at the board of directors for the first time in 2009 as independent non- executive member. Since 2021 he is Chairman of the Board of Directors. 

Loukia Lavida

Board Vice President

Born in Athens, Loukia “Vana” Lavidas holds a B.Sc. in Economics from Deree College in Athens and an MBA from La Verne University. She is fluent in English and French. After a long experience in charity foundations and especially after serving for nine years as Secretary General of ELPIDA (Friend’s Association of Children with Cancer),  she co-founded the Muscular Dystrophy Association (MDA Hellas), an Association for the care and welfare of those with neuromuscular disorders in Greece. Since its establishment in 2000, she serves as President of the Board. During its 22 years of operations, MDA Hellas has founded three fully equipped clinics in major public hospitals in Athens, Salonica and Patras, aiming at the provision of specialized services. Moreover, the Association has founded and operates with own means the “Home of MDA”, a fully accessible space at the center of Athens that provides for education, amusement and therapeutic gymnastics to peopled with muscular disorders. Today, MDA Hellas supports more than 1.400 family across Greece. She is also a Trustee member of the American College (ACG) and a board member of the Friends of National Art Gallery in Athens.

Telemaque Jean Lavidas

Chief Executive Officer

Born in New York, USA and raised in Athens, Greece, Telemaque holds a BA economics degree from Columbia University, NY. In 2003, he joined Lavipharm Laboratories, the R&D arm in the USA, as Assistant Project Manager. In 2006, he assumed the position of Business Development Director and in 2009 he returned to Greece, where up to 2013 he managed all commercial operations of the Group as Chief Commercial Officer (CCO), responsible for five Business Units (BUs), Pharma Rx, ConsumerHealth, International, Wholesaling and 3rd Party Logistics, and pharmacy network services (Pharma PLUS). In 2013, he founded Mediterra, a fast-growing health food company based in NY. In 2021, he returned to Greece and he took helm of the Lavipharm Group, serving as Executive Board Member and since 2024 as Chief Executive Officer. He is fluent in Greek, English, French. Since 2022, he is a member of the Hellenic Entrepreneurs Association (EENE).

Telemaque Lavidas represents the 4th generation of the Lavidas family in Greece, while he continues to perpetuate the pharmaceuticals business know-how successfully.

Panagiotis Giannouleas

Deputy Chief Executive Officer

Born in Piraeus, he holds a B.Sc. in Computer Science & Engineering from La Verne University, California, U.S.A.. He started his career in 1996 at Boehringer Ingelheim Hellas as a Medical Representative, he then became Head of the CRM & Business Planning Department, and at a young age he was promoted to Sales Manager for the local market. In 2008, he moved to Angelini Pharma Hellas as Marketing and Sales Manager. Since 2012 and for 7 years he served as the General Manager of the company in Greece and Bulgaria. In 2019, he joined Lavipharm as Chief Operations Officer & Country Manager of the Group and in 2024 he was elected in the Board of Directors assuming the responsibilities of Deputy CEO. He has served as a board member of the Federation of Companies active in selfcare medicines, while he is an elected board member of SFEE (Hellenic Association of  Pharmaceutical Companies). In 2024, he co-chaired the organising committee of the 3-day EEFAM conference on pharmaceutical management.

Christos Diamandopoulos

Non-Executive Board Member

Born in Athens, Professor Christos Diamandopoulos holds a PhD in Administrative Science from  the University of Pennsylvania, USA, (full scholarship) a Master’s’ degree in France from the Universite de Paris II (Sorbonne), full scholarship,  and a BA from the National and Kapodistriakon University of Athens. He has worked internationally both in the scientific and professional areas. In Greece, he served as special advisor to the Prime Minister of the Hellenic Republic. He has also worked for many years as an advisor on financial, administrative and managerial affairs in large industries and multinational companies. He has lectured for many years in the National School of Public Administration (Organisation of State and Project Management), of which he has also been one of the founding members in 1985. He has also lectured at the Democritus, University of Thrace (Human Resources Administration, Organisation models and Political Economy), at the Kapodistriako University of Athens (Decision Making Systems and Human Resources Administration), and at the University of Peloponese (Strategic Planning and Economics in Master’s’ Degree level). He is also responsible for all research programs of the Research Institute of the University of Athens, Institute for European Integration. He has published many studies on organisation, economic methodology and history of economic thought in miscellaneous scientific journals as well as newspapers and online sources. He speaks fluently English, French and German. Today is a permanent member of the Scientific Committee in Economic Research at the “Ludwig von Mises Institute Europe” (the Austrian Academia of Scientists) in Vienna and Brussels.

Sofia Kounenaki Efraimoglou

Independent, Non-Executive Board Member

Mrs. Sophia Kounenaki-Efraimoglou is Vice President of the Board of Directors of the Foundation of the Hellenic World, Chairman & Managing Director of Ardittos Holdings SA – a company of the Foundation of the Hellenic World, Head of “Hellenic Cosmos” Cultural Centre and Member of the Board of Directors of Athens Exchange Group. She is Elected President of the National Chamber Network of Greek Women Entrepreneurs, as well as Treasurer of the BoD at ALBA Graduate Business School. In 2008, as a Board Member at SEV, she initiated and led the developing of the Hellenic Corporate Governance Code as well as the subsequent establishment of the Greek Corporate Governance Council in 2012. She serves as board member to various bilateral business councils and national associations, while she is also a member of the Business Advisory Council of the MBA International Program of the Athens University of Economics and Business. Mrs. Kounenaki-Efraimoglou has been President and CEO of Vivodi Telecom and President of Fortius Finance Securities S.A., companies which she both founded. She holds undergraduate and postgraduate Degrees in Philosophy, Psychology, Business Administration, Finance and Computer Programming and speaks English, French and Italian. She has been awarded among others by the Region of Attica for her outstanding entrepreneurship, as well as the Navy, the Hellenic National Defense General Staff, the Unesco Club and the Tourism Awards Organization for her service to the country. In 2022, she has been appointed President of the Athens Chamber of Commerce and Industry, being the first chairwoman elected.

James Christopoulos

Independent, Non-Executive Board Member

Mr. James Christopoulos is Senior Managing Director at CVC Capital Partners, whom he joined in 2014. CVC Capital Partners is one of the largest investment funds in the world, managing over $120 billion in capital, with a global presence. CVC has a long-standing track record and expertise investing in healthcare services and, in Greece, is the majority shareholder of Metropolitan Hospital, IASO General and Hygeia Group (Hygeia, Mitera, Leto) through its subsidiary Hellenic Healthcare SA. Prior to joining CVC, Mr. Christopoulos worked for ten years at Investcorp International, Inc., where he led investments in services companies. Previously he was in the leveraged finance team at UBS. Mr. Christopoulos holds a bachelor’s degree in Economics from Columbia University, NY and is fluent in Greek, English, French and German.

Vicky D. Kefalas

Independent, Non-Executive Board Member

Vicky D. Kefalas was born in New York, USA in 1969 and holds a B.A. in Economics from the City University of New York and an M.B.A. in Finance from Pace University in New York. Ms Kefala has a long track record and experience in finance and investments, in European financing instruments, in innovation and sustainable investments, as well as in representing shareholder interests in complex, international transactions. She is based in Athens and since 2012 is the Head of Investments for Consolidated Contractors Company.

Ms Kefalas is also a member of the Investment Committee of InvestEU Fund of the European Commission. Furthermore, she is a member of the European Innovation Council in Brussels, responsible for strategic advice on innovation funding and policy in Europe and, the Athens Urban Transport Organization board in Athens, responsible for mass transport in Athens. For the latter, she is also a member of the Audit Committee.

Also, she has served on the Investment Committee of the European Fund for Strategic Investments (EFSI) and has been a member of the World Economic Forum’s Global Future Council on Infrastructure, being the co-contributor to a number of published papers of the Forum.

Corporate Secretary has been appointed Ms. Eleana Nikolopoulou,  Group Head of Legal & Compliance.

Born in Athens, she is Attorney at Law, admitted in the Athens Bar Association, graduate of National & Kapodistrian University of Athens Law School (LLB), Ludwig Maximilian University of Munich (LL.M), accredited Mediator and DPO. She started her professional career in 2000 as legal advisor at construction company HOCHTIEF AG involved in the New Athens International Airport Project. Following its completion, she expertise in the field of banking and insurance market as legal counsel of Eurobank, Eurolife and Viva Wallet. She is fluent in English, German and French.

(The term of the above members of the Board ends on 09/07/2027.)